Effect of Advertisements on Treatment Compliance in Women With Breast Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00462410|
Recruitment Status : Completed
First Posted : April 19, 2007
Last Update Posted : January 23, 2012
RATIONALE: Measuring how advertising affects treatment compliance in women with breast cancer may help doctors plan the best treatment.
PURPOSE: This clinical trial is studying how advertisements affect treatment compliance in women with breast cancer.
|Condition or disease||Intervention/treatment||Phase|
|Breast Cancer||Other: counseling intervention Procedure: psychosocial assessment and care||Not Applicable|
- Evaluate the consequences of advertisement on treatment compliance in women with breast cancer.
- Determine the factors favoring or not favoring adherence to the medical recommendations.
OUTLINE: Patients and their medical and nonmedical caregivers are interviewed by a sociologist or anthropologist twice over 1 year. The first interview is at the consultation visit and the second interview is at the patient's home. The impact of advertisement on treatment compliance is measured.
PROJECTED ACCRUAL: A total of 65 patients will be accrued for this study.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||65 participants|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Socio-anthropological Study Evaluating the Impact of Observance or Treatment in Patients With Breast Cancer|
|Study Start Date :||March 2006|
|Actual Primary Completion Date :||May 2011|
- Treatment compliance
- Factors affecting adherence to the medical plan
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00462410
|Study Chair:||Marc Debled, MD||Institut Bergonié|